Accolade (NASDAQ:ACCD) is set to give its latest quarterly earnings report on Thursday, 2022-06-30. Here's what investors need to know before the announcement.
Analysts estimate that Accolade will report an earnings per share (EPS) of $-0.66.
Gainers
ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.3% to $1.03 during Wednesday's after-market session. The company's market cap stands at $33.2 million.
Accolade's (NASDAQ:ACCD) short percent of float has fallen 9.9% since its last report. The company recently reported that it has 4.30 million shares sold short, which is 7.74% of all regular shares that are available for trading.